Volume 25 | June 2026

Maine SUD Learning Community Newsletter
 
 
CCSME logo

2026 HIGHLIGHTS

Gordon Smith, Esq

 

Gordon H. Smith, Esq. was appointed by Governor Janet Mills as Director of Opioid Response in January 2019. He is responsible for coordinating and directing Maine’s response to the opioid crisis, including prescriber education and reduction of opioid prescribing, prevention and treatment of substance use disorder, and harm reduction strategies. He stepped down as the Executive Vice President (EVP) of the Maine Medical Association in January 2019, where he had served as its EVP since September 1993 and where he began as General Counsel in 1981. He graduated from the University of Maine with the highest distinction in 1973 and from the Boston College Law School, magna cum laude, in 1976. He is a past Chairman of the American Society of State Medical Association Counsel, a nation-wide group of 140 attorneys representing medical associations.

 

8th Annual Opioid Response Summit

Thursday, July 16, 2026 | 8:00 AM - 5:00 PM

Cross Insurance Center, Bangor, Maine


Governor Janet Mills will host her 8th Annual Opioid Response Summit on Thursday, July 16, 2026, at the Cross Insurance Center, Bangor.



The annual summit convenes leaders from around Maine and the nation to share ideas, strategies, and best practices to help Maine people affected by the opioid crisis.

With the theme Building Hope, Honoring Progress, Inspiring Change, this full-day, in-person program will include keynote speakers and breakout sessions, with the voices of persons in recovery, featured prominently again this year.

FACULTY CORNER

SUD Learning Community Journal Club


Hello colleagues,


How addictive is kratom? As a treatment provider, your sample is enriched with the folks who have tried to stop but cannot. This generates a perception of danger that may or may not be warranted. At the same time, it turns a statistic about how many people develop a use disorder into a textured understanding of what that means for an individual and the people around them.

 

The article reviewed here- one that includes a few potentially pro-kratom authors- attempts to answer this question. It is one of few clinically relevant studies about kratom, let alone about its more sinister synthetic friends like 7-OH mitragynine and mitragynine pseudoindoxol (with opioid receptor affinities similar to morphine and fentanyl respectively) who are probably not included in this cohort. The dearth of information about kratom is so great that there are no treatment trials. Our management of kratom use disorders (KUDs) is based on an understanding of pharmacology, case reports and expert opinion.

 

In this mostly US based cross sectional study, drawn from respondents to an online survey, 25.5% of the people met criteria for KUD and 1/3 of those were in the moderate to severe range. The sample was relatively educated – all were at least high school graduates or had a GED, 50% were college educated and half were married; and only 16% reported diagnosis of a separate SUD, perhaps biasing toward a healthier population.

 

So is 25.5% a lot? It is probably more than for alcohol – among Americans as a whole, the prevalence of an alcohol use disorder is 10-11% (Bailey, et al 2025) and among those who drink at all, it is ~17% (Krist and Bradley, 2025). It is probably on par or less addictive than cocaine. These are challenging comparisons to make across studies, though, as it depends on sampling, inclusion criteria and how the diagnosis was made. With cocaine use for example[1], among those who have used in the past year, the rate of a use disorder is approximately 17% while among weekly users the rate is estimated at 49.9% (Mustaquim et al, 2021 and Cougle et al, 2016). 

 

Is (powder or leaf) kratom use disorder as consequential as other SUDs? In the group studied here, severity was moderate to severe in 1/3 of people with a KUD (and 8.9% overall). A review of the results table pasted below shows that among most people with KUD there is tolerance (81%), withdrawal (68%), craving (57%) and increased use over time (54%). Anecdotally, KUD is manageable with partial opioid agonists and fairly straightforward to stabilize in comparison to fentanyl use and to kratom’s synthetic derivative, 7OH mitragynine.

 

Kratom – even in its powder or leaf form is addictive. How addictive is a difficult number to pinpoint, but is probably higher than what we read here among the most vulnerable. What we do with that information, as imperfect as it is, depends on where you stand. From a public health and provider perspective it seems that at a minimum, substantial safeguards (age limits, strict labeling and clear messaging about risk and assurance of product integrity) are warranted.

 

Andrea Truncali, MD MPH 

 
FREQUENTLY ASKED QUESTIONS
 
 

How can healthcare providers better support breastfeeding for families affected by substance use disorder?

 


The Guidelines for the Use of Human Milk in the Context of Substance Use Disorder offers evidence-based recommendations to support safe breastfeeding practices, reduce stigma, and promote trauma-informed care for families impacted by SUD.

For these questions and technical assistance, contact the ME SUD Learning Community

 

RESOURCES & WEBINARS

ASAM 4th Edition Training



ASAM Criteria, 4th Edition Training

Brought to you by the Maine Office of Behavioral Health

No Cost to Maine Providers


Upcoming virtual live 2-day courses

July 23 & 24 and Sept 10 & 11

&

On-Demand 4-hour course


Contact Richard.freund@maine.gov to register

Young Adult ECHO: Supporting Affected Others

A 2021 study found that positive involvement of affected others in SUD treatment improves the treatment outcomes for an SUD client regardless of their age and the treatment model used. Conversely, affected others are at a higher risk of developing an SUD themselves. Affected others, commonly composed of impacted family members, friends, and community members, regularly report receiving few if any services. This ECHO series will explore strategies providers and their teams can incorporate into practice to meet the needs of affected others, as well as their SUD patients.

 
 

Supporting Affected Others in Relation to Homelessness

June 26, 2026 | 12:00 pm - 1:00 pm

Speaker: Tobias Nicholson| Maine Medical Center


 

Supporting Grandparents Raising Grandchildren due to SUD

July 10, 2026 | 12:00 pm - 1:00 pm

Speaker: Megan Dolbin-MacNab, PhD

The Hanley Center for Health Leadership and Education designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Funding for this initiative was made possible (in part) by grant no.1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Upcoming Webinars

 

Beers Criteria and Alternatives for Older Adults

June 17, 2026 | 12:00 pm - 1:00 pm

Speaker: Judith Beizer PharmD

 

Clonidine in Maine’s Carceral Setting: Pharmacology, Prescribing Practices, and Safety Considerations

June 25, 2026 | 12:00 pm - 1:00 pm

Speaker: Jessika Morin , M.D.| Nicolette Centanni, PharmD,BGCP,BCPP

 

Practical Prescribing and Treatment Strategies for Alcohol Use Disorder: Bridging Evidence and Everyday Practice

July 24, 2026 | 12:00 pm - 1:00 pm

Speaker: Amelia Hersey PA-C

Personal Recovery Story

 

Finding Strength in Sobriety

____________



BY AMY PARRADYSZ


Monique Coombs champions wellness and resilience in Maine’s fishing communities

Monique Coombs of Harpswell has made it her mission to normalize conversations about sobriety—so much so that her LinkedIn profile says:

 

Expanding the Conversation

 

This series highlights the lived experiences of individuals in recovery to inform clinical best practices in treating Substance Use and Opioid Use Disorders (SUD/OUD). These are not simple “success stories,” but honest accounts of what helped—and what didn’t—during treatment. By centering the voices of those seeking care, we aim to support clinicians and their teams in delivering more compassionate, evidence-based treatment and reducing overdose deaths.

 

View full series here.

 

Online Self Paced Courses

Pressed for time?

Enroll in one of our convenient online self-paced courses today!

For our complete course list, please visit the ME SUD Learning Community website.

Online Self-paced Courses

Learn the principles and ways to apply them to welcome people into your practice.

Webinar Video| Podcast

Please visit the ME SUD Learning Community website for upcoming Events and Resources.

Brought to you by the Maine Substance Use Disorder Learning Community,

funded by Maine DHHS with funding by the Maine Office of Behavioral Health. Coordinated by CCSME.